Article Text

Download PDFPDF

PTH-115 Comparison of immunogenicity of biosimilar infliximab and originator infliximab in children with inflammatory bowel disease in real life setting
  1. A Wahid,
  2. R Muhammed
  1. Department of Gastroenterology, Birmingham Children’s Hospital, Birmingham, UK

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.